Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERFECT 1: Trifarotene in acne vulgaris
NCT02566369Phase 3Completed
- Sponsor
- Galderma
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Countries
- 5
01
Overview
A Phase 3 trial of CD5789 cream vehicle in acne vulgaris, sponsored by Galderma. Started Nov 2015; status: completed.
02
Drugs
CD5789 cream vehicle
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02566369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566369.